Kolexia
Ollivier-Hourmand Isabelle Gastro-entérologie
Ollivier-Hourmand Isabelle
Gastro-entérologie
Hôpital Côte de Nacre
Caen, France
103 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose Carcinome hépatocellulaire Carcinomes Cirrhose du foie Thrombose Tumeurs du foie Maladies du foie Hépatite Hypertension portale

Collaborateurs

Voir plus
Dao Manh Thong
Dao Manh Thong
Hôpital Côte de Nacre, Caen, France
Bronowicki Jean Pierre
Bronowicki Jean Pierre
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Nguyen-Khac Eric
Nguyen-Khac Eric
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France
Bureau Christophe
Bureau Christophe
Hôpital Purpan, Toulouse, France

Industries

Voir plus
Ipsen
8 collaboration(s)
Dernière en 2022
Abbvie
2 collaboration(s)
Dernière en 2023
Bayer
2 collaboration(s)
Dernière en 2020
Gilead
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
PRO-SURFASA: Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis, a National Prospective Multicentre Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   11 mars 2024
ProPILARifax: A Multicenter, Double-blind, Placebo-controlled Randomized Clinical Trial Comparing Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites : Using or Not Using Rifaximin
Essai Clinique (CHU Besançon)   04 mars 2024
CARVECIR: Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial
Essai Clinique (CHU Tours)   16 février 2024
Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination a Vascular Liver Disease Group (VALDIG) initiative.
Hepatology (Baltimore, Md.)   15 février 2024
Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 96 weeks: a retrospective multicenter european study (SAVE-D)
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Impact of socio-economic environment on incidence of primary liver cancer in France between 2006 and 2016.
Liver international : official journal of the International Association for the Study of the Liver   27 novembre 2023
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
Hepatology (Baltimore, Md.)   06 novembre 2023
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations.
BMC gastroenterology   12 septembre 2023
Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study.
JHEP reports : innovation in hepatology   22 août 2023